Please provide your email address to receive an email when new articles are posted on . The closer diabetic macular edema is to the center of the macula, the more likely it is to eventually involve ...

Amy Nguyen Howell, MD, MBA, highlights the importance of data collection, analysis, and the new ICD-10-CMZ codes in understanding and resolving health disparities in diabetic macular edema patient ...

New real-world data confirm Vabysmo’s potent retinal drying in nAMD and DMEKey data for Susvimo demonstrate its potential to provide lasting disease control through continuous delivery, while reducing ...

Post-hoc analyses from four phase III studies indicate Vabysmo dried retinal fluid faster with fewer injections in neovascular or ‘wet’ age-related macular degeneration (nAMD) and diabetic macular ...

4D Molecular Therapeutics reports positive interim data for 4D-150 in wet AMD and DME, with strong financial position and strategic focus. 4D Molecular Therapeutics announced positive interim data for ...

Eylea just lost its data edge on archrival Lucentis in a key patient group. Two-year data from a head to head trial found that the two drugs were equally effective in patients with diabetic ...

BOWIE, Md., Oct. 4, 2012 /PRNewswire/ -- Inovalon, Inc., a leading provider of data-driven healthcare solutions, today announced it has received the Encounter Data Processing System (EDPS) ...

Across all DME patients dosed to date, 4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose level 3E10 vg/eye demonstrated strong signals of ...

Earlier this year, Regeneron ($REGN) scored a win when its eye drug Eylea outperformed a pair of Roche ($RHHBY) meds in a head-to-head study. And now, that win is ...